mGnP

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07562152Immuneering CorporationPhase 3Recruiting2028-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.